Global Genomic Data Analysis & Interpretation

Global Genomic Data Analysis & Interpretation Market Research Report: Forecast (2022-2027)

By Product Type (Software, Services (Licenses & Maintenance)), By Genomic Platform (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray), By Application (Research (Omics Data Read more

  • Healthcare
  • Nov 2021
  • 221
  • HC55020

Genomic Data Analysis & Interpretation enables researchers to adopt statistical & computational methods to decode the information hidden in DNA sequences. These tools allow clinical experts to understand how DNA differences can affect human health & diseases.

The Global Genomic Data Analysis & Interpretation Market is likely to grow at a CAGR of around 11.10% during the forecast period, i.e., 2022-27, says MarkNtel Advisors. The market growth attributes principally to the burgeoning cancer cases worldwide, encouraging numerous biotechnology companies to develop genomic software solutions for data analysis to help clinicians provide precision oncology treatments.

Moreover, the surging applications of Next-Generation Sequencing (NGS) in cancer research, declining costs of sequencing, and the mounting number of genomic research initiatives by both emerging & developed countries are other prominent factors expected to drive the market over the forecast years, further states the research report, "Global Genomic Data Analysis & Interpretation Market Analysis, 2022."

Report Coverage Details
Study Period Historical Data: 2017-20
Base Year: 2021
Forecast Period: 2022-27
CAGR 11.10%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain, The Netherlands
Asia-Pacific: China, India, Japan, South Korea, Australia and Others
South America: Brazil, and Others
Middle East & Africa: UAE, Saudi Arabia, South Africa
Key Companies Profiled Agilent Technologies Inc., ThermoFisher Scientific, Asuragen Inc., BGI Genomics Co., Ltd, 10X Genomics Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd, DNASTAR, Golden Helix Inc., Illumina Inc., Oxford Nanopore Technologies Inc., Pacific Biosciences of California Inc., Partek Inc., QIAGEN NV, SoftGenetics LLC
Unit Denominations USD Million/Billion

 

Impact of Covid-19 on the Global Genomic Data Analysis & Interpretation Market

  • With the Covid-19 pandemic in 2020, most industries worldwide observed a decelerating impact, yet the Global Genomic Data Analysis & Interpretation Market underwent a balanced effect.
  • The accelerated spread of Covid-19 pressurized the Healthcare sector to research & develop medications & vaccines.
  • However, movement restrictions & frequent lockdowns imposed by the governments of different countries hindered the supply chain and brought considerable delays in clinical research.
  • On the other hand, the market also witnessed a rising demand for data analysis & interpretation tools to preserve extensive data sharing associated with viral sequencing to identify how SARS-CoV-2 evolves & spreads.
  • Observing this urgency & criticality of the crisis, market giants boosted their research & development initiatives and invested significantly to develop effective Covid-19 treatment.
  • Hence, the coming years are likely to create remunerative growth opportunities for the leading players participating in the Global Genomic Data Analysis & Interpretation Market.

Global Genomic Data Analysis & Interpretation Market Research Report: Forecast (2022-2027)

Market Segmentation:

Based on Application, the Global Genomic Data Analysis & Interpretation Market segments into:

  • Research
    • Omics Data Analysis (Transcriptomic, Microbiomics, Proteomics, Others)
    • Population Genomics
    • Annotation and Gene Expression
    • Others
  • Clinical
    • Oncology
    • Rare Diseases
    • Infectious Diseases
    • Others (Sexual & Reproductive Health, etc.)

Of both, the market growth is likely to be the fastest in terms of Clinical applications. The rapidly increasing cancer cases & clinical developments are significantly surging the need for next-generation diagnostic tests worldwide. Since these tests facilitate early diagnosis & enable efficient prognosis of various forms of cancer, the demand for genomic data analysis & interpretation tools is likely to witness the fastest growth for Oncology in the coming years. 

Demand for Next-Generation Sequencing (NGS) to Observe the Fastest Growth through 2027

The accelerating adoption of sequencing platforms for clinical diagnosis due to a significant decline in their installation costs and the easy access & availability of genomic & proteomic data are the prime factors expected to create the fastest growing demand for Next-Generation Sequencing (NGS) during 2022-27.

Furthermore, the growing use of bisulfite-methylation for targeted sequencing & targeted methylation NGS data analysis methods is also projected to propel the adoption of NGS and drive the market in the coming years, states MarkNtel Advisors in their research report, “Global Genomic Data Analysis & Interpretation Market Analysis, 2022.”

Regional Landscape

Based on the Geography, the Global Genomic Data Analysis & Interpretation Market expands across:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Here, North America is expected to dominate the market with the largest share through 2027. It owes to the various initiatives by government agencies & prominent market players toward conducting research & development on genomics & bioinformatics. Besides, the increasing cases of cancer, growing awareness about precision medication, and reducing costs of sequencing are other crucial aspects boosting the market across North America.

Moreover, one of the most prominent market players in the US, like ThermoFisher Scientific, is expected to continue its dominance in the region during 2022-27 due to its substantial funding toward providing medical experts with reliable genomic software for data analysis required in precision oncology treatments.

On the other hand, Asia-Pacific is expected to witness the fastest market growth in the coming years, principally due to the rapidly increasing adoption of sequencing, coupled with rapid advancements in molecular biology leading to several genome sequencing initiatives & programs across the region.

Moreover, the active participation of leading players like Illumina Inc. is further contributing to the market expansion. The leader introduced its cloud-based BaseSpace Sequence Hub in China, facilitating storage management & interpretation of genomics data. Such initiatives are likely to accelerate the regional market growth over the forecast years.

Market Dynamics:

Key Drivers

  • Reducing costs of sequencing
  • Increasing cancer cases worldwide
  • Mounting number of population genomics programs

Possible Restraints

  • Unavailability of high complexity genomic testing centers across potential regional markets
  • Inadequate awareness regarding advanced diagnostic capabilities
  • Lack of knowledge over the utilization of technologies across research centers due to fewer training programs

Key Questions Answered in the Market Research Report:

  1. What are the overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares) of the Global Genomic Data Analysis & Interpretation Market?
  2. What are the region-wise industry size, drivers, and challenges?
  3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Genomic Data Analysis & Interpretation Market?
  4. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Genomic Data Analysis & Interpretation Market based on the competitive benchmarking matrix?
  5. What are the key results derived from surveys conducted during the Global Genomic Data Analysis & Interpretation Market study?

Frequently Asked Questions

A. The Global Genomic Data Analysis & Interpretation Market is likely to grow at a CAGR of around 11.10% during the forecast period, i.e., 2022-27.

A. Oncology is anticipated to emerge as an opportunity area for leaders and drive the market in the forecast period.

A. Declining costs of sequencing and the rapidly increasing cancer cases worldwide are the prime aspects anticipated to drive the Global Genomic Data Analysis & Interpretation Market during 2022-27.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Market Segmentation
  2. Executive Summary
  3. Impact of Covid-19 on Genomics Data Analysis & Interpretation Market Analysis
  4. Global Genomics Data Analysis & Interpretation Market Policies & Regulations
    1. The US
    2. Europe
    3. Asia Pacific
  5. Global Genomics Data Analysis & Interpretation Market Trends & Insight
  6. Global Genomics Data Analysis & Interpretation Market Dynamics
    1. Impact Analysis
    2. Drivers
    3. Challenges
  7. Global Genomics Data Analysis & Interpretation Market Hotspot & Opportunities
  8. Global Genomics Data Analysis & Interpretation Market Analysis, 2017-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Product Type
        1. Software
        2. Services
          1. Licenses
          2. Maintenance
      2. By Genomic Platform
        1. Next Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
        3. Microarray
        4. Others
      3. By Application
        1. Research
          1. Omics Data Analysis
            1. Transcriptomic
            2. Microbiomics
            3. Proteomics
            4. Others
          2. Population Genomics
          3. Annotation and Gene Expression
          4. Others
        2. Clinical
          1. Oncology
          2. Rare Diseases
          3. Infectious Diseases
          4. Others (Sexual & Reproductive Health, etc.)
      4. By End-User
        1. Hospitals and Diagnostic Laboratories
        2. Biotechnological & Pharmaceutical Companies
        3. Research and Academic Institutes
        4. Others (Contract Research Organizations, Forensic Laboratories, etc.)
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia Pacific
      6. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  9. North America Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Product Type
      2. By Application
      3. By End-User
      4. By Country
        1.  US
        2.  Canada
        3.  Mexico
    3.  US Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1.  By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    4. Canada Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    5. Mexico Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
  10. South America Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Product Type
      2. By Modality
      3. By Procedure
      4. By End-User
      5. By Country
        1. Brazil
        2. Others
    3. Brazil Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
  11. Europe Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Product Type
      2. By Application
      3. By End-User
      4. By Country
        1. UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. The Netherlands
        7. Others
    3.  UK Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    4.  Germany Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    5.  France Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    6.  Italy Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    7.  Spain Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    8. The Netherlands Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
  12.  Middle East & Africa Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Product Type
      2. By Application
      3. By End-User
      4. By Country
        1. UAE
        2. Saudi Arabia
        3. South Africa
        4. Others
  13. Asia Pacific Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Product Type
      2. By Application
      3. By End-User
      4. By Country
        1. India
        2. China
        3. Japan
        4. Australia
        5. South Korea
        6. Others
    3.  India Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    4.  China Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    5.  Japan Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    6. Australia Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
    7.  South Korea Genomics Data Analysis & Interpretation Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenue
      2. Market Share & Analysis
        1. By Product Type
        2. By End-User
  14. Competition Outlook
    1. Competition Matrix
      1. Target Markets
      2. Research & Development
      3. Collaborations & Strategic Alliances
      4. Business Restructuring – Mergers, Acquisitions, JVs
      5. Strategic Initiatives
    2. Company Profiles (Business Description, Demand Segments, Market Focused Demand Segment, Business Segments, Market Focused Business Segment, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. Agilent Technologies Inc.
      2. ThermoFisher Scientific
      3. Asuragen Inc.
      4. BGI Genomics Co., Ltd
      5. 10X Genomics Inc.
      6. Bio-Rad Laboratories
      7. F. Hoffmann-La Roche Ltd
      8. DNASTAR
      9. Golden Helix Inc.
      10. Illumina Inc.
      11. Oxford Nanopore Technologies Inc.
      12. Pacific Biosciences of California Inc.
      13. Partek Inc.
      14. QIAGEN NV
      15. SoftGenetics LLC
  15. Disclaimer
Global Genomic Data Analysis Interpretation Market Segmentation